🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to determine whether, in patients with moderate...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-07
Trial ID
NCT00941031
This study assessed efficacy of secukinumab, compared to ustekinumab, in pa...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-02-26
Trial ID
NCT02074982
Treatments Being Tested
The purpose of this study is to demonstrate the efficacy and safety of secu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-10-03
Trial ID
NCT02721966
Treatments Being Tested
The purpose of this study is to assess long term safety in participants who...
Status
Recruiting
Location
Providence Medical Foundation
Start Date
2020-12-22
Trial ID
NCT04638647
Treatments Being Tested
The purpose of the present study was to assess the efficacy of secukinumab ...
Status
Terminated
Location
Millennium Clinical Trials
Start Date
2023-08-10
Trial ID
NCT05722522
Treatments Being Tested
To demonstrate that the efficacy of secukinumab 300 mg at Week 16 was super...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-06-27
Trial ID
NCT02798211
Treatments Being Tested
This study was designed to evaluate the efficacy and safety of secukinumab ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-01-30
Trial ID
NCT03765788
Treatments Being Tested
The purpose of this pivotal trial is to evaluate subcutaneous (SQ) AIN457 a...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-10
Trial ID
NCT00995709
The purpose of this study was to demonstrate the clinical efficacy, safety ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-04-29
Trial ID
NCT02696031
Treatments Being Tested
The aim of this study was to describe the effect of direct IL-17A inhibitio...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-01-14
Trial ID
NCT03553823
Treatments Being Tested